Esser will work with scientists to accelerate the development of new medicines and treatments for illnesses like cancer and Alzheimer's.
Bioscience & Health Care
The University advances innovation in bioscience and health care delivery by supporting research and sustained growth for startups and bioscience initiatives. Partnerships with powerful industry leaders like INOVA create impact throughout the state and beyond.
Filter by Region, Sector, or Focus
One of Esser's responsibilities will be to foster an "ecosystem of innovation" that will attract biotechnology and pharmaceutical companies to Central Virginia and the greater Commonwealth, bringing with them hundreds of jobs directly and…
UVA Health
AgroSpheres, a biotechnology company pioneering breakthroughs in sustainable crop protection and crop health.
Agrospheres
A mobile health platform developed at the University of Virginia that is being licensed by a UVA Licensing & Ventures Group company - with guidance from its Entrepreneurs in Residence program - is making the lives of people with HIV around…
UVA Today
Discover the University's contributions to Virginia through a series of compelling, vignette-style highlights presented in this first edition report. Understand UVA as an engine for inclusive economic growth by exploring the initiatives that…
University of Virginia School of Medicine professor Lee Ritterband created SHUTi (Sleep Healthy Using the Internet) – a digital therapeutic that uses cutting-edge technology to administer cognitive behavioral therapy for people suffering from insom
UVA Today
Local biotechnology industry leader Nikki Hastings, PhD, has been named the first Executive Director of the CvilleBioHub, a non-profit that connects and supports the Charlottesville-area biotechnology sector.  CvilleBioHub will receive strategic pla
Charlottesville Tomorro…
The UVA Licensing & Ventures Group helps discoveries reach their full potential in the marketplace. In 2018 there were 213 invention disclosures filed, 59 U.S. patents issued and 77 transactions with commercial partners. 
UVA Licensing &…
A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.
WMRA
Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).
Charlottesville Tomorro…
The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.
UVA Today
Professor Gregory B. Fairchild is the first director of Northern Virginia operations for the University of Virginia.
UVA Today